The Phoenix Mills Ltd. (PDF)
Trending Sector
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
SIP Calculator
Retirement Planning Calculator
Adani Ports and SEZ
Glaxosmithkline Pharmaceuticals Ltd. Share Price
Glaxosmithkline Pharmaceuticals Ltd. (INR)2657.8-25.3 (-0.9%) 
Exchange ScripsBSE500660NSEGLAXOISININE159A01016
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Glaxosmithkline Pharmaceuticals Ltd. Performance
Market performance
Open price2690
High2695.1
Volumes62016
Prev Close2657.8
Low2640.05
Closing date2025-03-13
Historical performance
1 Year High3088.00
3 Year High3088.00
5 Year High3088.00
1 Year Low1842.05
3 Year Low1227.00
5 Year Low973.00
Glaxosmithkline Pharmaceuticals Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
45147
Face Value (₹)
10
P/E Ratio
76.32
Dividend Yield
0.12 %
Glaxosmithkline Pharmaceuticals Ltd. Investment Returns
1 Year
38%
3 Years
72.1%
5 Years
110.1%
10 Years
60.8%
Glaxosmithkline Pharmaceuticals Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 2681.95 | Bearish |
| 10-DMA | 2643.62 | Bullish |
| 20-DMA | 2536.81 | Bullish |
| 50-DMA | 2270.8 | Bullish |
| 100-DMA | 2349.28 | Bullish |
| 200-DMA | 2528.72 | Bullish |
Shareholding Pattern
| Field | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 4 |
| Foreign Investors | 4 | 4 | 4 | 4 | 4 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 119621 | 119224 | 118511 | 118990 | 114659 |
| Government | 3 | 2 | 2 | 2 | 3 |
Glaxosmithkline Pharmaceuticals Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 1226 | 1007 | 758 | 1106 |
| Operating Profit | 10313 | 9049 | 8377 | 7087 |
| Interest | 18 | 18 | 20 | 35 |
| Depreciation | 697 | 658 | 682 | 786 |
| Profit Before Tax | 8162 | 8364 | 7790 | 4540 |
| Consolidated Net Profit | 5900 | 6107 | 16947 | 3581 |
| Adjusted EPS | 35 | 36 | 100 | 21 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 1694 | 1694 | 1694 | 1694 |
| Total Reserves | 16172 | 15735 | 24935 | 13089 |
| Minority Interest | --- | --- | --- | --- |
| Total Non-Current Liabilities | 1077 | 1254 | 1587 | 1787 |
| Total Liabilities | 34103 | 31930 | 45201 | 30115 |
| Capital Work in Progress | 139 | 203 | 305 | 132 |
| Total Assets | 34103 | 31930 | 45201 | 30115 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 5820 | 4842 | 8107 | 5779 |
| Cash Flow from Investing Activities | 87 | 8079 | -4055 | 4180 |
| Cash Flow from Financing Activitie | -5615 | -15433 | -5242 | -6956 |
| Net Cash Inflow / Outflow | 292 | -2512 | -1190 | 3004 |
34%
Negative
Neutral
Positive
- The stock has a PE ratio of 76.32.
- 3Y Stock Price CAGR of the stock is 19.6.
- The stock has a beta of 0.6.
- In the last financial year, the company had an EBITDA of ₹10313 Million.
- The company generated revenue of ₹34537 Million in the previous financial year.
Glaxosmithkline Pharmaceuticals Ltd.
2657.8-25.3 (-0.9%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1349788
No. of Shares: 507.9
Performance:35%
P/L: ₹349788
Top Gainers
| Symbol | Change% |
|---|---|
| HITECHCORP | 197.05(20%) |
| NACLIND | 92.38(16%) |
| GANDHITUBE | 728.2(15%) |
| FAIRCHEMOR | 1021.9(14%) |
| MTNL | 48.88(13%) |
Similar stocks
Announcing Stock of the Month!
